Role of ferritin alterations in human breast cancer cells

Breast Cancer Research and Treatment

Volumn 126, Issue 1, 2011, Pages 63-71

  Shpyleva, Svitlana I ^a,b   Tryndyak, Volodymyr P ^a   Kovalchuk, Olga ^c   Starlard Davenport, Athena ^a   Chekhun, Vasyl F ^b   Beland, Frederick A ^a   Pogribny, Igor P ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^c UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Breast cancer; Ferritin; Iron; MicroRNA miR 200

Indexed keywords

DOXORUBICIN; FERRITIN; MICRORNA; MICRORNA 200B; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION;

ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL NUCLEUS; DOXORUBICIN; FEMALE; FERRITINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 78649673239     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0849-4     Document Type: Article

References (42)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 10.3322/caac.20006 19474385
2. AM Gonzalez-Angulo F Morales-Vasquez GN Hortobagyi 2007 Overview of resistance to systematic therapy in patients with breast cancer Adv Exp Med Biol 608 1 22 1:CAS:528:DC%2BC3cXhtlKgsb7I 10.1007/978-0-387-74039-3-1 17993229
3. DB Longley PG Johnston 2005 Molecular mechanism of drug resistance J Pathol 205 275 292 1:CAS:528:DC%2BD2MXhsFOgsrk%3D 10.1002/path.1706 15641020 (Pubitemid 40227997)
4. L O'Driscoll M Clynes 2006 Biomarkers and multiple drug resistance in breast cancer Curr Cancer Drug Targets 6 365 384 10.2174/156800906777723958 16918307 (Pubitemid 44033389)
5. HM Coley 2008 Mechanism and strategies to overcome chemotherapy resistance in metastatic breast cancer Cancer Treat Rev 34 378 390 1:CAS:528:DC%2BD1cXmtlWiurY%3D 10.1016/j.ctrv.2008.01.007 18367336
6. S Raguz E Yagüe 2008 Resistance to chemotherapy: new treatments and novel insights into an old problem Br J Cancer 99 387 391 1:CAS:528: DC%2BD1cXptFSntb4%3D 10.1038/sj.bjc.6604510 18665178
7. JG Lieghr JS Jones 2001 Role of iron in estrogen-induced cancer Curr Med Chem 8 839 849
8. GC Kabat TE Rohan 2007 Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis Cancer Causes Control 18 1047 1053 10.1007/s10552-007-9058-9 17823849 (Pubitemid 47498168)
9. X Huang 2008 Does iron have a role in breast cancer? Lancet Oncol 9 803 807 1:CAS:528:DC%2BD1cXpsVCht7c%3D 10.1016/S1470-2045(08)70200-6 18672216 (Pubitemid 352038319)
10. P Arosio R Ingrassia P Cavadini 2009 Ferritins: a family of molecules for iron storage, antioxidation and more Biochim Biophys Acta 1790 589 599 1:CAS:528:DC%2BD1MXnt1yjtL4%3D 18929623
11. FM Torti SV Torti 2002 Regulation of ferritin genes and protein Blood 99 3505 3516 1:CAS:528:DC%2BD38XjvVGnsrY%3D 10.1182/blood.V99.10.3505 11986201 (Pubitemid 34534516)
12. RE Weinstein BH Bond BK Silberberg 1982 Tissues ferritin concentration in carcinoma of the breast Cancer 50 2406 2409 1:STN:280:DyaL3s%2FltVGisw%3D%3D 10.1002/1097-0142(19821201)50:11<2406::AID-CNCR2820501127>3.0.CO;2-S 7139533 (Pubitemid 13244177)
13. G Günner G Kirkali C Yenisey IR Töre 1992 Cytosol and serum ferritin in breast carcinoma Cancer Lett 67 103 112 10.1016/0304-3835(92)90132-F (Pubitemid 23054876)
14. NA Higgy AM Salicioni IH Russo PL Zhang J Russo 1997 Differential expression of human ferritin H chain gene in immortal human breast epithelial MCF-10F cells Mol Carcinog 20 332 339 1:CAS:528:DyaK1cXitVemsg%3D%3D 10.1002/(SICI)1098-2744(199712)20:4<332::AID-MC2>3.0.CO;2-L 9433477 (Pubitemid 28078727)
15. DC Yang F Wang RL Elliot JF Head 2001 Expression of transferring receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer Anticancer Res 21 541 549 1:CAS:528:DC%2BD3MXjtVeru7Y%3D 11299801 (Pubitemid 32267568)
16. A Mackay C Jones T Dexter RLA Silva K Bulmer A Jones P Simpson RA Harris PS Jat AM Neville LFL Reis SR Lakhani MJ O'Hare 2003 cDNA microarray analysis of genes associated with ERB2 (HER2/neu) overexpression in human mammary luminal epithelial cells Oncogene 22 2680 2688 1:CAS:528:DC%2BD3sXjtlKjtL0%3D 10.1038/sj.onc.1206349 12730682 (Pubitemid 36605615)
17. YQ Li H Yan B Bai 2008 Change in iron transporter expression in human term placenta with different maternal iron status Eur J Obstet Gynecol Reprod Biol 140 48 54 1:CAS:528:DC%2BD1cXhtVens73I 10.1016/j.ejogrb.2008.02.012 18586377
18. TD Schmittgen KJ Livak 2008 Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 3 1101 1108 1:CAS:528:DC%2BD1cXmvVemt7c%3D 10.1038/nprot.2008.73 18546601 (Pubitemid 351818697)
19. KH Zhang HY Tian X Gao WW Lei Y Hu DM Wang XC Pan ML Yu GJ Xu FK Zhao JG Song 2009 Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition Cancer Res 69 5340 5348 1:CAS:528: DC%2BD1MXnvFWqu7o%3D 10.1158/0008-5472.CAN-09-0112 19531652
20. O Kakhlon ZI Cabantchik 2002 The labile iron pool: characterization, measurement, and participation in cellular processes (1) Free Radic Biol Med 33 1037 1046 1:CAS:528:DC%2BD38Xns1Sisb0%3D 10.1016/S0891-5849(02)01006-7 12374615
21. Tryndyak VP, Beland FA, Pogribny IP (2010) E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer (in press)
22. M Trudeau F Charbonneau K Gelmon K Laing J Latreille J Mackey D McLeod K Pritchard L Provencher S Verma 2005 Selection of adjuvant chemotherapy for treatment of node-positive breast cancer Lancet Oncol 6 886 898 1:CAS:528:DC%2BD2MXhtFOmsb%2FI 10.1016/S1470-2045(05)70424-1 16257797 (Pubitemid 41614801)
23. JC Kwok DR Richardson 2002 The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Crit Rev Oncol Hematol 42 65 78 10.1016/S1040-8428(01)00213-X 11923069 (Pubitemid 34229148)
24. S Toyokuni 2009 Role of iron in carcinogenesis: cancer as a ferrotoxic disease Cancer Sci 100 9 16 1:CAS:528:DC%2BD1MXhtlGguro%3D 10.1111/j.1349-7006. 2008.01001.x 19018762
25. RE Weinstein BH Bond BK Silberberg CB Vaughn P Subbaiah DR Pieper 1989 Tissue ferritin concentration and prognosis in carcinoma of the breast Breast Cancer Res Treat 14 349 353 1:STN:280:DyaK3c7itlahtA%3D%3D 10.1007/BF01806307 2611407 (Pubitemid 20053765)
26. N Modjtahedi T Frebourg N Fossar C Lavialle C Cremisi O Brison 1992 Increased expression of cytokeratin and ferritin-H genes in tumorigenic of the SW 613-S human colon carcinoma cell line Exp Cell Res 201 74 82 1:CAS:528:DyaK38Xlt12js7w%3D 10.1016/0014-4827(92)90349-D 1377134
27. CG Wu M Groenink A Bosma PH Reitsma SJH van Deventer RAFM Chamuleau 1997 Rat ferritin-H: cDNA cloning, differential expression and localization during hepatocarcinogenesis Carcinogenesis 18 47 52 10.1093/carcin/18.1.47 9054589 (Pubitemid 28134616)
28. KJ Wu A Polack R Dalla-Favera 1999 Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC Science 283 676 679 1:CAS:528:DyaK1MXot1Oqtg%3D%3D 10.1126/science.283.5402.676 9924025 (Pubitemid 29075004)
29. A Calzolari I Oliviero S Deaglio G Mariani M Biffoni NM Sposi F Malavasi C Peschle U Testa 2007 Transferrin receptor 2 is frequently expressed in human cancer cell lines Blood Cells Mol Dis 39 82 91 1:CAS:528:DC%2BD2sXlsF2ru7k%3D 10.1016/j.bcmd.2007.02.003 17428703 (Pubitemid 46754920)
30. DR Richardson DS Kalinowski S Lau PJ Jansson DB Lovejoy 2009 Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents Biochim Biophys Acta 1790 702 717 1:CAS:528:DC%2BD1MXnt1yjurg%3D 18485918
31. A Baldi T Battista A De Luca D Santini L Rossiello F Baldi PG Natali D Lombardi M Picardo A Felsani MG Paggi 2003 Identification of genes down-regulated during melanoma progression: a cDNA array study Exp Dermatol 12 213 218 1:CAS:528:DC%2BD3sXksVWgtLs%3D 10.1034/j.1600-0625.2003.00026.x 12702151 (Pubitemid 36934707)
32. HO Habashy DG Powe CM Staka EA Rakha G Ball AR Green M Aleskandarany EC Paish R Douglas Macmillan RI Nicholson IO Ellis JM Gee 2010 Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen Breast Cancer Res Treat 119 283 293 1:CAS:528:DC%2BD1MXhsFyjs7fL 10.1007/s10549-009-0345-x 19238537
33. F Lin AW Girotti 1997 Elevated ferritin production, iron containment, and oxidant resistance in hemin-treated leukemia cells Arch Biochem Biophys 346 131 141 1:CAS:528:DyaK2sXmsVantro%3D 10.1006/abbi.1997.0300 9328293 (Pubitemid 27415304)
34. S Epsztejn H Glickstein V Picard IN Slotki W Breuer C Beaumont ZI Cabantchik 1999 H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties Blood 94 3593 3603 1:CAS:528:DyaK1MXnsVansro%3D 10552971 (Pubitemid 29536156)
35. PO Berberat M Katori E Kaczmarek D Anselmo C Lassman B Ke X Shen RW Busuttil K Yamashita E Csizmadia S Tyagi LE Otterbein S Brouard E Tobiasch FH Bach JW Kupiec-Weglinski MP Soares 2003 Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury FASEB J 17 1724 1726 1:STN:280:DC%2BD3svhvFaguw%3D%3D 12958189
36. A Cozzi B Corsi S Levi P Santambrogio A Albertini A Arosio 2000 Overexpression of wild type and mutated human ferritin H-chain in HeLa cells J Biol Chem 275 25122 25129 1:CAS:528:DC%2BD3cXmtVeitbc%3D 10.1074/jbc.M003797200 10833524
37. A Baldi D Lombardi P Russo A Palescandolo A De Luca D Santini F Baldi L Rossielo ML Dell'Anna A Mastrofrancesco V Maresca E Flori PG Natali M Picardo MG Paggi 2005 Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress Clin Cancer Res 11 3175 3183 1:CAS:528:DC%2BD2MXjslOqsLs%3D 10.1158/1078-0432.CCR-04-0631 15867210 (Pubitemid 40627862)
38. MK Kiessling CD Klemke MM Kaminski IE Galani PH Krammer K Gülow 2009 Inhibition of constrictively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma Cancer Res 69 2365 2374 1:CAS:528:DC%2BD1MXjtFyqtb8%3D 10.1158/0008-5472.CAN-08- 3221 19258503
39. U Burk J Schubert U Wellner O Schmalhofer E Vincan S Spaderna T Brabletz 2008 A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells EMBO Rep 9 582 589 1:CAS:528:DC%2BD1cXmsFykt7Y%3D 10.1038/embor.2008.74 18483486 (Pubitemid 351772923)
40. PA Gregory AG Bert EL Paterson SC Barry A Tsykin G Farshid MA Vadas Y Khew-Goodall GJ Goodall 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat Cell Biol 10 593 601 1:CAS:528:DC%2BD1cXltl2is7c%3D 10.1038/ncb1722 18376396 (Pubitemid 351627379)
41. GJ Hurteau IA Carlson E Roos GJ Brock 2009 Stable expression of miR-200c alone is sufficient to regulate TCF (ZEB1) and restore E-cadherin expression Cell Cycle 8 2064 2069 1:CAS:528:DC%2BC3cXovFyqsw%3D%3D 10.4161/cc.8.13.8883 19502803
42. DC Yang RL Elliott JF Head 2002 Gene targets of antisense therapies in breast cancer Expert Opin Ther Targets 6 375 385 1:CAS:528:DC%2BD38XltlOksr4%3D 10.1517/14728222.6.3.375 12223074 (Pubitemid 34662108)